Sent: Tuesday, July 05, 2005 4:43 PM
Subject: FDA MedWatch - Liqiang 4 Dietary Supplement Capsules contain unla
beled glyburide and pose health risk


MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA notified consumers and healthcare professionals about the risks of
taking Liqiang 4 Dietary Supplement Capsules because they contain glyburide
- a drug that could have serious, life-threatening consequences in some
people. The product is manufactured by Liqiang Research Institute, China,
and marketed throughout the United States in herbal stores and through mail
order by Bugle International of Northridge CA. Glyburide is a drug used to
lower blood sugar, and is safe and effective when used as labeled in
FDA-approved medications. People who have low blood sugar or those with
diabetes can receive dangerously high amounts of glyburide by consuming
Liqiang 4. Consumers should immediately stop using these products and seek
medical attention, especially if they are currently being treated with
diabetes drugs or if they have symptoms of fatigue, excessive hunger,
profuse sweating, or numbness of the extremities.

Read the complete MedWatch 2005 Safety summary, including a link to the FDA
Talk Paper, at:

http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#liqiang

--------